IgG4表达和肿瘤入侵前的IgG4/IgG比率预测了肝内胆管癌患者的长期预后。
IgG4 expression and IgG4/IgG ratio in the tumour invasion front predict long-term outcomes for patients with intrahepatic cholangiocarcinoma.
发表日期:2023 Feb 03
作者:
Takahiro Yoshizawa, Takeshi Uehara, Mai Iwaya, Shiho Asaka, Tomoyuki Nakajima, Yasuhiro Kinugawa, Akira Shimizu, Koji Kubota, Tsuyoshi Notake, Hitoshi Masuo, Hiroki Sakai, Kiyotaka Hosoda, Hikaru Hayashi, Tadanobu Nagaya, Hiroyoshi Ota, Yuji Soejima
来源:
PATHOLOGY
摘要:
报道称,在肿瘤微环境中,IgG4阳性浆细胞增加,并且许多癌症中肿瘤中的这些细胞数量较高是一个不良的预后因素。然而,在肝内胆管癌(ICC)中没有报道IgG4表达的分析。本研究旨在分析ICC患者的与预后相关的临床病理特征与IgG4表达之间的关系。我们鉴定了2010年1月至2020年12月间接受手术切除的37名ICC患者。通过免疫染色法分析了肿瘤、侵入前缘和肿瘤附近基质中IgG阳性和IgG4阳性浆细胞的数量。此外,我们研究了预后相关临床病理数据与ICC患者IgG4阳性浆细胞数量和IgG4/IgG比率之间的关系。 肿瘤内区域、侵入前缘和靠近肿瘤的非癌组织区域(NCA)中IgG4阳性浆细胞的百分比分别为91.9%、56.8%和81.1%。对于除一例NCA组织外的所有病例,每个区域都观察到IgG阳性浆细胞。侵入前缘中高IgG4表达水平和IgG4/IgG比率与不良总生存率(OS)显着相关(Logrank检验p=0.0438和p=0.0338,分别)。OS的多元分析表明,高IgG4表达(p=0.0140)、淋巴结转移(p=0.0205)和手术切缘阳性(p=0.0009)或高IgG4/IgG比率(p=0.0051)、淋巴结转移(p=0.0280)和手术切缘阳性(p=0.0009)是独立的不良预后因素。总之,侵入前缘中高IgG4表达水平和IgG4/IgG比率是ICC的独立不良预后因素。针对IgG4的靶向治疗可能改善ICC患者的预后。版权所有©2023年澳大利亚病理学皇家学院。由Elsevier B.V.出版。保留所有权利。
IgG4-positive plasma cells are reportedly increased in the tumour microenvironment, and a high number of these cells in tumours is a poor prognostic factor in several cancers. However, there are no reported analyses of IgG4 expression in intrahepatic cholangiocarcinoma (ICC). This study aimed to analyse the correlations between prognosis-related clinicopathological features of patients with ICC and IgG4 expression. We identified 37 ICC patients who underwent surgical resection between January 2010 and December 2020. The number of IgG-positive and IgG4-positive plasma cells in the tumour, invasion front, and stroma near the tumour was analysed by immunostaining. Furthermore, we examined the association of prognosis-related clinicopathological data with the number of IgG4-positive plasma cells and IgG4/IgG ratio in ICC patients. The IgG4-positive plasma cell percentages for the intra-tumour area, invasion front, and non-cancerous area (NCA) near the tumour were 91.9%, 56.8%, and 81.1%, respectively. IgG-positive plasma cells were observed in each region for all cases, except for NCA tissue in one case. A high IgG4 expression level and IgG4/IgG ratio in the invasion front were significantly associated with poor overall survival (OS) (log-rank test p=0.0438 and p=0.0338, respectively). Multivariate analysis for OS revealed that high IgG4 expression (p=0.0140), lymph node metastasis (p=0.0205), and positive surgical margin (p=0.0009) or a high IgG4/IgG ratio (p=0.0051), lymph node metastasis (p=0.0280), and positive surgical margin (p=0.0009) were independent poor prognostic factors. In conclusion, a high IgG4 expression level and IgG4/IgG ratio in the invasion front are independent poor prognostic factors for ICC. Targeted therapy for IgG4 may improve the prognosis for patients with ICC.Copyright © 2023 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.